Evidence map›Paper›PMID 30836930›Full record

ArticleCurrent molecular pharmacology2019

Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage.

Keane K Y Lai, Cu Nguyen, Kyung-Soon Lee, Albert Lee, David P Lin, Jia-Ling Teo, Michael Kahn

Open access · hybridAbstract read
In one paragraph

Article in Current molecular pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. A Model of Butyrate Activity and Resistance in CRC.Journal of cellular and molecular medicine · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Keane K Y LaiDepartment of Pathology, City of Hope National Medical Center, Duarte, California, United States.
Cu NguyenDepartment of Molecular Medicine, Beckman Research Institute, City of Hope, Duarte, California, United States.
Kyung-Soon LeeDepartment of Pharmacology, University of Washington, Seattle, Washington, United States.
Albert LeeChildren's Hospital Los Angeles, Los Angeles, California, United States.
David P LinDepartment of Molecular Medicine, Beckman Research Institute, City of Hope, Duarte, California, United States.
Jia-Ling TeoDepartment of Molecular Medicine, Beckman Research Institute, City of Hope, Duarte, California, United States.
Michael KahnDepartment of Molecular Medicine, Beckman Research Institute, City of Hope, Duarte, California, United States.
City of Hope · USChildren's Hospital of Los Angeles · USCity Of Hope National Medical Center · USUniversity of Washington · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI William Dean Wallace · 1985 to 2026
$181.4M
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Efficacy of Novel Wnt Modulator in Colon CancerR01CA166161 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAHN, MICHAEL, LENZ, HEINZ JOSEF · 2013 to 2017
$2.3M
Mechanisms of beta-catenin signaling in alveolar epithelial cell differentiationR01HL112638 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA, KAHN, MICHAEL · 2013 to 2016
$2.2M
Stearoyl-CoA Desaturase in Alcohol-Promoted Liver TumorigenesisK08AA025112 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAI, KEANE · 2017 to 2021
$978k
Modulation of Wnt Signaling in Models of Multiple SclerosisR21NS074392 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GILMORE, WENDY · 2012 to 2013
$444k
Innate enteric immunity during induced Paneth cell deficiencyR21AI105057 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OUELLETTE, ANDRE J. · 2013 to 2014
$440k
NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA166161NHLBI NIH HHS R01 HL112638NIAAA NIH HHS K08 AA025112
6 · The paper itself

Abstract

backgroundThe ancient and highly evolutionarily conserved Wnt signaling pathway is critical in nearly all tissues and organs for an organism to develop normally from embryo through adult. Wnt signaling is generally parsed into "canonical" or Wnt-β-catenin-dependent or "non-canonical" β-catenin-independent signaling. Even though designating Wnt signaling as either canonical or noncanonical allows for easier conceptual discourse about this signaling pathway, in fact canonical and non-canonical Wnt crosstalk regulates complex nonlinear networks.

objectiveIn this perspective, we discuss the integration of canonical and non-canonical Wnt signaling via differential Kat3 (CBP and p300) coactivator usage, thereby regulating and coordinating gene expression programs associated with both proliferation and cellular differentiation and morphogenesis.

methodsPharmacologic inhibitors, cell culture, real-time PCR, chromatin immunoprecipitation, protein immunoprecipitation, Western blotting, reporter-luciferase, protein purification, site-directed mutagenesis, in vitro phosphorylation and binding assays, and immunofluorescence were utilized.

conclusionCoordinated integration between both canonical and non-canonical Wnt pathways appears to be crucial not only in the control of fundamental morphologic processes but also in the regulation of normal as well as pathologic events. Such integration between both canonical and non-canonical Wnt signaling is presumably effected via reversible phosphorylation mechanism (e.g., protein kinase C) to regulate differential β -catenin/Kat3 coactivator usage in order to coordinate proliferation with differentiation and adhesion.

Indexed as

Wnt Signaling Pathway3T3 CellsAnimalsCell DifferentiationCell LineCell Line, TumorCell ProliferationCREB-Binding ProteinE1A-Associated p300 ProteinHumansMiceCREB-Binding ProteinCREBBP protein, humanE1A-Associated p300 ProteinEP300 protein, humancanonicalCBPKat3 coactivatornon-canonicalp300.Wnt

Identifiers

PMID30836930
PMCPMC6687580
OpenAlexW2919459147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.